N

Nosis Bio

Biotech firm delivering cell-targeted RNA therapeutics

Senior Scientist in Pharmacology

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeAlameda, CA, USANo salary listedIn-person

About the Job

Requirements

  • A PhD in Molecular Biology, Biochemistry, Genetics, Pharmacology, Bioengineering, or a related field, or an equivalent combination of advanced training and relevant industry experience.
  • Deep hands-on experience with quantitative PCR methods and molecular assay development, including work with complex tissue or biofluid samples.
  • Demonstrated ability to design pharmacology studies, interpret pharmacokinetic and pharmacodynamic readouts, and integrate molecular results with cross-functional datasets.
  • Experience with RNA therapeutic development, including preclinical pharmacology data preparation and presentation for scientific and regulatory interactions.
  • Ability to work on site in the laboratory at Research Park at Marina Village in Alameda, California.

Responsibilities

  • Design and lead quantitative molecular biology studies supporting pharmacokinetic, pharmacodynamic, biodistribution, target engagement, and gene expression assessments.
  • Develop, optimize, qualify, and oversee workflows for RNA and DNA extraction, cDNA synthesis, RT-qPCR, qPCR, ddPCR, and related molecular assays across programs.
  • Establish robust sample-processing workflows across cells, tissues, and biofluids, including homogenization, lysis, cleanup, quantification, normalization, and RNase-free handling.
  • Translate program questions into study strategies with appropriate controls, acceptance criteria, replication, timelines, and sample requirements.
  • Analyze and integrate complex datasets, including relative and absolute quantification, assay performance metrics, and relationships among molecular, exposure, efficacy, and other pharmacology readouts.
  • Lead troubleshooting and root-cause investigations for assay and instrument performance, and implement durable improvements to experimental workflows.
  • Establish and maintain standard operating procedures, assay qualification summaries, data analysis templates, and training materials that support reproducible execution across the team.
  • Ensure accurate, real-time documentation in the electronic lab notebook, including protocols, raw data, deviations, quality-control decisions, and scientific interpretation.
  • Coordinate cross-functionally so sample generation, handling, analysis, and reporting remain aligned with study objectives and program timelines.
  • Present data with clear context, controls, conclusions, and recommendations, and use the results to guide experimental plans and program decisions.
  • Lead quantitative molecular biology strategy across one or more pharmacology programs, aligning assay plans with biological questions, technical feasibility, and program priorities.
  • Own molecular assay platforms end to end, including capability building, performance tracking, risk identification, resource planning, and continuous improvement.
  • Identify and implement new technologies, analytical approaches, and external capabilities that expand the pharmacology toolkit.
  • Mentor scientists and research associates, providing technical guidance and maintaining a high bar for rigor, reproducibility, documentation, and scientific interpretation.
  • Serve as a scientific leader across functions and external collaborations, integrating molecular and in vivo evidence into program strategy and scientific communications.

About the Company

Nosis Bio

Biotech firm delivering cell-targeted RNA therapeutics

Nosis Bio develops cell-targeted RNA medicines using its Connexa platform, which combines physics-informed deep learning, generative AI, and high-throughput biochemistry to design Targeted Delivery Vehicles for RNA therapies. Connexa builds a receptome atlas mapping human receptors, identifying over 2,900 cell-specific targets to allow gene silencing in precise cell types, including difficult tissues like the CNS. The company pursues a wholly owned pipeline while partnering with big pharma to apply its platform to high-value indications. Its goal is to enable safer, re-dosable RNA medicines that reach previously hard-to-target tissues, expanding treatment options for fibrosis, immune and cardiovascular diseases.

Company size
Not listed
Company stage
Not listed
Total funding
Not listed
Headquarters
Berkeley, CA
Founded
2021

Recently Posted Jobs

Explore more opportunities at Nosis Bio

See more jobs